Induction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor

Critical Care Medicine

Volumn 25, Issue 5, 1997, Pages 827-833

  Ogle, Cora K ^a,b   Guo, Xialing ^a   Chance, William T ^a   Ogle, James D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Complement component C3; Interleukin 6; Lipopolysaccharide; Prostaglandin E2; Splenic macrophage

Indexed keywords

COMPLEMENT COMPONENT C3; ENDOTOXIN; INTERLEUKIN 6; PROSTAGLANDIN E2; RECOMBINANT TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MARROW; CATTLE; COMPLEMENT C3; DINOPROSTONE; DRUG COMBINATIONS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030960150     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199705000-00019     Document Type: Article

References (52)

1. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 228:869-871
2. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474
3. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-664
4. Tracey KJ, Lowry SF, Fahey TJ, et al: Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164:415-422
5. Christman JW, Holden EP, Blackwell TS: Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 1995; 23:955-963
6. Fukushima R, Alexander JW, Gianotti L, et al: Isolated pulmonary infection acts as a source of systemic tumor necrosis factor. Crit Care Med 1994; 22:114-120
7. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486
8. Miller-Graziano CL, Kodys K, Gonzalez F, et al: Continued tumor necrosis factor receptor expression by trauma patients' monocytes (Mphi) despite TNF alpha secretion. Shock 1994; 1:317-324
9. 2 by lipopolysaccharide-stimulated rat bone marrow macrophages after thermal injury: Effect of indomethacin. Inflammation 1994; 18:175-185
10. Wilson JD Jr, Stewart RM, Fabian TC, et al: Plasma tumor necrosis factor and post-traumatic hyperdynamic sepsis evoked by endotoxin. Shock 1994; 1:176-183
11. Sheppard BC, Norton JA: Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor. Surgery 1991; 109: 698-705
12. Alexander HR, Doherty GM, Block MI, et al: Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats. Infect Immun 1991; 59:3889-3894
13. Sheppard BC, Fraker DL, Norton JA: Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery 1989; 106:156-162
14. Alexander HR, Doherty GM, Fraker DL, et al: Human recombinant interleukin-1α protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res 1991; 150:421-424
15. Alexander HR, Sheppard BC, Jensen JC, et al: Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of Gram-negative sepsis. J Clin Invest 1991; 88:34-39
16. Fraker DL, Stovroff MC, Merino MJ, et al: Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 1988; 168:95-105
17. Manthey CL, Vogel SN: The role of cytokines in host responses to endotoxin. Rev Med Microbiol 1992; 3:72-79
18. Li Y, Chen B: Differential regulation of fyn-associated protein tyrosine kinase activity by macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). J Leukoc Biol 1995; 57:484-490
19. Ikebuchi K, Wong GG, Clark SC, et al: Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotent hemopoietic progenitors. Proc Natl Acad Sci U S A 1987; 84: 9035-9039
20. Khoury FM, Lemoine M, Baillou C, et al: Tumor necrosis factor alpha in human long-term bone marrow cultures: Distinct effects on nonadherent and adherent progenitors. Exp Hematol 1992; 20:991-997
21. Zamir O, Hasselgren P-O, James H, et al: Effect of tumor necrosis factor or interleukin-1 on muscle amino acid uptake and the role of glucocorticoids. Surg Gynecol Obstet 1993; 177:27-32
22. Chance WT, Cao L, Nelson JL, et al: Acivicin reduces tumor growth during total parenteral nutrition (TPN). Surgery 1987; 102:386-394
23. 2 by splenic, alveolar and peritoneal guinea pig macrophages. Prostaglandins 1988; 36:279-289
24. Ruff MR, Gifford GE: Tumor necrosis factor. In: Lymphokines. Vol 2. Pick E (Ed). New York, Academic Press, 1981, pp 235-273
25. Aarden LA, DeGroot ER, Schaap OL, et al: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17:1411-1416
26. Shacter E, Arzadon GK, Williams J: Elevation of interleukin-6 in response to a chronic inflammation stimulus in mice: Inhibition by indomethacin. Blood 1992; 80:194-202
27. Ogle CK, Guo X, Alexander JW: The activation of bone marrow macrophages 24 hours after thermal injury. Arch Surg 1993; 128:96-101
28. 2 and the cytotoxicity of stimulated bone marrow macrophages after thermal injury and the cytotoxicity of stimulated U-937 macrophages. Inflammation 1993; 17: 583-594
29. Ogle CK, Wu J-Z, Mao X, et al: Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation 1994; 18:511-523
30. Rogers JA, Berman JW: TNF-α inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures. J Immunol 1994; 153:4694-4703
31. Sten E, Jacobsen W, Ruscetti FW, et al: Tumor necrosis factor α directly and indirectly regulates hematopoietic progenitor cell proliferation: Role of colony stimulating factor receptor modulation. J Exp Med 1992; 175:1759-1772
32. Fong Y, Tracey KJ, Moldawer LL, et al: Antibodies to cachectin/tumor necrosis factor reduce interleukin 10 and interleukin 6 appearance during lethal bacteremia. Exp Med 1989; 170: 1627-1633
33. Imamura K, Spriggs D, Kufe D: Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J Immunol 1987; 139:2989-2992
34. Beutler BA, Milsark IW, Cerami AC: Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135:3972-3977
35. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988; 263: 5380-5384
36. Fahmi H, Chaby R: Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites. Cell Immunol 1993; 150:219-229.
37. Ding AE, Sanchez S, Srimal S: Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 1989; 264:3924-3939
38. Holtmann H, Wallach D: Down-regulation of the receptors for tumor necrosis factor by interleukin-1 and 4B-phorbol-12-myristate-13-acetate. J Immunol 1987; 139:1161-1167
39. Henricson BE: Analysis of the cellular and molecular mechanisms which underlie sensitivity to bacterial endotoxin and early endotoxin tolerance. PhD Dissertation. Bethesda, MD, Uniformed Services University of the Health Sciences, 1992
40. Henricson BE, Benjamin WR, Vogel SN: Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect Immun 1990; 59:1188-1191
41. Vogel SN, Hogan MM: The role of cytokines in endotoxin-mediated responses. In: Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation. Oppenheim JJ, Shevach E (Eds). New York, Oxford University Press, 1990, pp 239-258
42. Madonna GS, Vogel SN: Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J Immunol 1985; 135:3763-3771
43. Henricson BE, Manthey CL, Perera PY, et al: Dissociation of lipopolysaccharide (lipopolysaccharide)-inducible gene expression in murine macrophages pretreated with smooth lipopolysaccharide versus monophosphoryl lipid A. Infect Immun 1993; 61:2325-2333
44. Madonna GS, Peterson GS, Ribi EE, et al: Early-phase endotoxin tolerance: Induction by a detoxified lipid A derivative, monophosphoryl lipid A. J Immunol 1985; 135:3763-3771
45. Madonna GS, Vogel SN: Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice. Infect Immun 1986; 53:707-710
46. Vogel SN, Kaufman E, Tate M, et al: Recombinant interleukin-1α and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 1988; 56:2650-2567
47. Henricson BE, Neta R, Vogel SN: An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun 1991; 59:1188-1191
48. Vogel SN, Havell EA: Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody. Infect Immun 1990; 58:2397-2400
49. Mathison JD, Wolfson E, Ulevitch RJ: Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81:1925-1937
50. Virca GD, Kim SY, Glaser KB, et al: Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem 1989; 264: 21951-21956
51. Zuckerman SH, Evans GF, Butler LD: Endotoxin tolerance: Independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun 1991; 59:1774-2780
52. Li MH, Seatter SC, Manthei R, et al: Macrophage endotoxin tolerance: Effect of TNF or endotoxin pretreatment. J Surg Res 1994; 57:85-92